Morie Gertz
Known for addressing patient subgroups in CAR T-cell trials
Best podcasts with Morie Gertz
Ranked by the Snipd community
Aug 5, 2022 • 9min
Integrating BCMA-directed agents in the treatment landscape for relapsed/refractory MM
Experts discuss integrating BCMA-directed agents in MM treatment, challenges of CAR T-cell availability, potential of bispecific therapies, and ADCs. Emphasis on managing keratopathy, high response rates with combination therapies, and the importance of evaluating BCMA-directed agents in earlier lines of therapy.
